Austin Angelo

About the Author Austin Angelo


Freeport-McMoRan Gets a Sell Rating from Berenberg Bank

In a report issued on June 28, Fawzi Hanano from Berenberg Bank maintained a Sell rating on Freeport-McMoRan (NYSE: FCX), with a price …

Roth Capital Reaffirms Their Hold Rating on Flex Pharma

Roth Capital analyst Jotin Marango maintained a Hold rating on Flex Pharma (NASDAQ: FLKS) on June 29. The company’s shares closed on Friday …

Pivotal Research Keeps a Buy Rating on Constellation Brands Inc

Pivotal Research analyst Timothy Ramey maintained a Buy rating on Constellation Brands Inc (NYSE: STZ) today and set a price target of $285. …

Pacira Pharmaceuticals Gets a Hold Rating from Mizuho Securities

In a report released today, Irina Rivkind Koffler from Mizuho Securities reiterated a Hold rating on Pacira Pharmaceuticals (NASDAQ: PCRX), with a price …

Oppenheimer Maintains a Buy Rating on Strongbridge Biopharma Plc

Oppenheimer analyst Hartaj Singh maintained a Buy rating on Strongbridge Biopharma Plc (NASDAQ: SBBP) today. The company’s shares opened today at $5.

Analysts Have Conflicting Sentiments on These Financial Companies: Welltower (WELL) and SunTrust Banks (STI)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Welltower (NYSE: WELL) and SunTrust Banks …

Analysts’ Opinions Are Mixed on These Financial Stocks: Franklin Street Properties (FSP) and CIT Group (CIT)

Analysts have been eager to weigh in on the Financial sector with new ratings on Franklin Street Properties (NYSE: FSP) and CIT Group …

Analysts Offer Insights on Consumer Goods Companies: CSW Industrials (CSWI) and Marvell (MRVL)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on CSW Industrials (NASDAQ: CSWI) …

VistaGen Therapeutics Gets a Buy Rating from Chardan Capital

In a report released today, Gbola Amusa from Chardan Capital maintained a Buy rating on VistaGen Therapeutics (NASDAQ: VTGN), with a price target …

Stifel Nicolaus Remains a Buy on Hospitality Properties

Stifel Nicolaus analyst Simon Yarmak maintained a Buy rating on Hospitality Properties (NYSE: HPT) today and set a price target of $30. The …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts